The correlation between GPER expression and clinicopathological determinants of BC progression, including survival, tumor size, number of positive lymph nodes, and vascular invasion, still remains to be understood [11,12,31,32,81,82,83]. The gene discussed is GPER1; the disease is breast cancer.